Evidence-Based Uses, Dosing, and Safety Profile
L-Theanine
L-theanine at 200-400 mg daily demonstrates robust evidence for improving attention and reducing stress, with emerging data supporting sleep quality enhancement at 200-450 mg daily. 1, 2
Proven Uses
Cognitive Enhancement: A single 200 mg dose taken 30-60 minutes before cognitive testing significantly improves choice reaction time and attention (effect size 0.51) 1. The effect on overall cognitive performance is consistent across trials.
Stress Reduction: Doses of 200-400 mg/day reduce both perceived and physiological stress markers under stress-inducing conditions, without causing sedation 3. The acute stress reduction effect is modest (effect size 0.31) but clinically meaningful 1.
Sleep Support: Supplementation with 200-450 mg/day improves sleep-related outcomes including sleep latency, maintenance, efficiency, and subjective sleep satisfaction 2, 3. Effects are seen on both objective and participant-reported measures.
Mood: Potential antidepressant effects with single doses showing significant reduction in depressive symptoms (effect size 0.69) in healthy individuals, though this requires confirmation in clinical populations 1.
Dosing Recommendations
- For attention/cognition: 100-400 mg as a single dose, taken 30-60 minutes before the desired effect
- For stress reduction: 200-400 mg daily
- For sleep support: 200-450 mg daily, typically taken in the evening
- Combination with caffeine: Enhances cognitive benefits when combined
Time to Effect
- Acute effects (attention, stress): 30-60 minutes after single dose
- Sleep improvements: Beneficial effects reported within days to weeks of consistent use
- Sustained benefits: Most trials demonstrate effects within 2-6 weeks of daily supplementation
Safety Profile
L-theanine is exceptionally safe with no serious adverse events reported across clinical trials 1, 3. It does not cause sedation or impair cognitive function. Well-tolerated across all studied populations with dropout rates similar to placebo.
Magnesium Bisglycinate
Magnesium bisglycinate at 250 mg elemental magnesium daily modestly improves insomnia severity in adults with poor sleep quality, with effects emerging by 4 weeks. 4
Proven Uses
Sleep Quality: In adults reporting poor sleep, 250 mg elemental magnesium daily as bisglycinate significantly reduced Insomnia Severity Index scores by Week 4 (reduction of -3.9 vs -2.3 for placebo, p=0.049) 4. The effect size is small (Cohen's d = 0.2), indicating modest benefit.
Potential High Responders: Exploratory analyses suggest notably greater improvements in individuals with lower baseline dietary magnesium intake 4, though this requires confirmation.
Critical Evidence Gap
The available evidence specifically for magnesium bisglycinate is limited to one recent high-quality trial 4. The broader gastroenterology guidelines address only magnesium oxide (MgO) for constipation, explicitly stating: "the bioavailability and clinical efficacy of other formulations of magnesium (eg, citrate, glycinate, lactate, malate, sulfate) for CIC are unknown" 5.
Dosing Recommendations
- For sleep support: 250 mg elemental magnesium daily (as bisglycinate)
- Timing: Typically taken in the evening
Time to Effect
- Sleep improvements: Significant effects observed by Week 4 of daily supplementation 4
Safety Profile
Well-tolerated in the studied population. Critical contraindication: Avoid in patients with renal insufficiency (creatinine clearance <20 mg/dL) due to risk of hypermagnesemia 5. This applies to all magnesium formulations as systemic regulation depends on renal excretion.
Magnesium L-Threonate (Magtein®)
Magnesium L-threonate at 2 g daily (delivering ~145 mg elemental magnesium) improves overall cognitive performance, working memory, and some subjective sleep measures over 6 weeks. 6
Proven Uses
Cognitive Enhancement: 2 g daily (as Magtein®) for 6 weeks significantly improved overall cognitive performance measured by NIH Total Cognition Composite (p=0.043), with larger effects on working and episodic memory 6. Also reduced estimated brain cognitive age by 7.5 years and improved reaction time (p=0.031).
Cardiovascular Markers: Greater reduction in resting heart rate (p=0.030) and increase in heart rate variability (p=0.036), indicating improved autonomic balance and stress reduction 6.
Sleep (Mixed Evidence): Improved sleep-related impairment based on self-report (p=0.043), with stronger effects in subset with more severe sleep problems (p=0.031). However, no group differences in objective sleep measures from wearable devices 6.
Regulatory Status
EFSA Panel concluded that magnesium L-threonate is safe at maximum intake of 3000 mg/day (corresponding to ~2730 mg L-threonate and 250 mg magnesium) in adults, except pregnant and lactating women 7. Magnesium is bioavailable from this source. The L-threonate component at 2700 mg/day is considered safe based on prior safety assessments.
Dosing Recommendations
- For cognitive enhancement: 2 g daily (Magtein®), delivering approximately 145 mg elemental magnesium
- Maximum safe dose: Up to 3000 mg daily per EFSA assessment 7
Time to Effect
- Cognitive improvements: Significant effects observed after 6 weeks of daily supplementation 6
- Cardiovascular markers: Changes in heart rate and HRV detected within 6 weeks
Safety Profile
Well-tolerated with no significant adverse reactions reported 6, 7. The NF may contain up to 1% oxalic acid; additional exposure of up to 30 mg daily from this source is not of safety concern 7. Same renal contraindication applies as with all magnesium formulations: avoid in creatinine clearance <20 mg/dL 5.
Key Clinical Considerations
Formulation-Specific Evidence
Only magnesium oxide has been evaluated in RCTs for constipation 5. The clinical efficacy and bioavailability of bisglycinate and L-threonate for purposes other than those specifically studied (sleep for bisglycinate, cognition for L-threonate) remain unknown.
Combination Approaches
Recent evidence suggests morning adaptogens combined with evening sleep supplements may have different effects than either alone 8. When combining L-theanine with magnesium formulations, monitor for cumulative effects on sleep and stress.
Population Considerations
- Healthy adults: Most evidence derives from healthy populations with self-reported concerns (poor sleep, stress)
- Clinical populations: Limited data in diagnosed insomnia, anxiety disorders, or cognitive impairment
- Renal impairment: Absolute contraindication for all magnesium supplements when creatinine clearance <20 mg/dL 5
Duration of Use
- L-theanine: Safe for continuous use; most trials range from single doses to 8 weeks
- Magnesium bisglycinate: Studied for 6 weeks; longer-term safety presumed based on general magnesium safety
- Magnesium L-threonate: Studied for 6 weeks; EFSA assessment supports longer-term use at recommended doses 7
Common Pitfalls
- Expecting immediate effects: Sleep and cognitive benefits typically require 2-6 weeks of consistent supplementation
- Ignoring renal function: Always assess kidney function before initiating any magnesium supplement
- Assuming formulation equivalence: Evidence for one magnesium formulation does not automatically apply to others
- Overlooking dietary magnesium: Individuals with adequate dietary intake may experience smaller benefits, particularly with magnesium supplements 4